Allara, a virtual care platform serving women of reproductive age with chronic hormonal conditions, has announced a $10M Series A funding round led by GV (Google Ventures). Participants in the funding round include Great Oaks Venture Capital, Humbition, Vanterra, Gaingels, and individual investors such as Tom Lee from One Medical and Maggie Sellers. Additionally, Frédérique Dame, GV’s General Partner, will join Allara’s Board of Directors.

Allara’s platform connects patients with specialist doctors and registered dietitians to provide ongoing care, addressing an existing gap in women’s healthcare. In the past year, Allara has expanded its patient base by five times. Currently, it’s in-network with all major insurance providers across eight states, representing 30 million insured individuals. With the new funding, Allara plans to extend its insurance coverage, partner with leading health systems for improved patient care, and conduct clinical research.

The platform was founded by Rachel Blank based on her personal experience with a PCOS diagnosis and the challenges she faced due to insufficient medical support. Blank stated, “Women’s health is often misperceived as limited to pregnancy and fertility, failing to acknowledge the intricate web of health conditions that affect women’s daily lives and long-term health. At Allara, we finally take the burden off the patient to navigate a siloed care system and empower her with a whole-body, preventative approach to her health. We are grateful for the support of GV and our dedicated partners to scale our operations and extend this vital care offering to women nationwide.”

Research indicates that over one-third of women live with chronic conditions such as PCOS, endometriosis, or hypothyroidism. Many women can spend up to 10 years without a proper diagnosis, leading to potential complications like infertility, high-risk pregnancies, obesity, and diabetes. These conditions, along with delayed treatments, have financial implications for the health system. Allara aims to address these issues by offering specialized care to this demographic.

Frédérique Dame, GV’s General Partner, commented on the investment, “Women of reproductive age have complex hormonal care needs, and Allara raises the bar for clinically driven, personalized hormonal healthcare. Allara has built a brand and community that hundreds of thousands of patients trust, and we’re excited to support CEO Rachel Blank and the team as they provide women with compassionate,
modern healthcare.”

Show CommentsClose Comments

Leave a comment